Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03330548 · ClinicalTrials.gov registry record · NA
Pilot Study on the Effects of a Plant-Strong Diet on Cardiovascular Risk Factors
A NA study of Diabetes and Overweight and Obesity, sponsored by Phoenix VA Health Care System.
- Completed
- Registry status
- NA
- Development phase
- 87
- Enrollment target
- 1
- Study location
NCT03330548: Completed NA study of Diabetes and Overweight and Obesity, sponsored by Phoenix VA Health Care System.
NCT03330548 is a NA study of Diabetes and Overweight and Obesity that has completed, run by Phoenix VA Health Care System. The registered enrollment target is 87 participants, below the 3,028-participant average among 338 other Diabetes trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03330548, a NA study of Diabetes and Overweight and Obesity, has completed, sponsored by Phoenix VA Health Care System.
- COMPLETED
- Registry status
- NA
- Development phase
- 87 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to conduct a preliminary test of the effectiveness of various educational interventions to promote adoption of a whole-food, plant-strong diet and reduce specific cardiovascular risk factors in Veterans, and subsequently perform a preliminary pilot study on whether this dietary approach will change plaque inflammation and endothelial function.
Primary Outcome
Fasting Low-density lipoprotein measured in milligrams per deciliter (mg/dl)
Conditions Studied
Interventions
- BEHAVIORAL TeleMOVE!
- BEHAVIORAL Culinary Rx
Study Locations (1)
Arizona
- Phoenix VA Health Care System - Phoenix
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 87 participants |
| Start Date | 2015-07-09 |
| Est. Completion | 2021-03-05 |
| Phase | NA |
What the finished NCT03330548 record still lists
NCT03330548 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 87 participants, a relatively small participant target, below the 3,028-participant average among 338 other Diabetes trials with a reported enrollment target (97% lower).
The record links to 3 conditions, with Diabetes appearing as the primary indexed condition, and to 2 interventions - of which TeleMOVE! is the first listed.
NCT03330548 reports a single indexed study location in Arizona.
Frequently Asked Questions
What is clinical trial NCT03330548 about?
NCT03330548 is a clinical study titled "Pilot Study on the Effects of a Plant-Strong Diet on Cardiovascular Risk Factors". The purpose of this study is to conduct a preliminary test of the effectiveness of various educational interventions to promote adoption of a whole-food, plant-strong diet and reduce specific cardiovascular risk factors in Veterans, and subsequently perform a preliminary pilot study on whether this ...
What is the current status of trial NCT03330548?
This trial is currently completed. It is a NA study. The enrollment target is 87 participants. The study started on 2015-07-09. Estimated completion is 2021-03-05.
What conditions does trial NCT03330548 study?
This clinical trial studies the following conditions: Diabetes, Overweight and Obesity, Hyperlipidemias.
What interventions are being tested in trial NCT03330548?
The interventions under investigation include: TeleMOVE! (BEHAVIORAL), Culinary Rx (BEHAVIORAL).
Who is sponsoring clinical trial NCT03330548?
This trial is sponsored by Phoenix VA Health Care System, which has 7 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03330548 being conducted?
This trial has 1 study location across Arizona. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetes
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03330548's enrollment target sits among peer trials
87 207th of 338 higher than 131 of 338 other Diabetes trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Diabetes trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Effect of 2-Week Continuous Glucose Monitoring on Glycemic Management in Patients New-to-Insulin on Hospital Discharge
RECRUITING · NA
-
Effects of Whole vs. Nonfat Milk Consumption on Body Composition in Children
RECRUITING · NA
-
Efficacy of Viome's Precision Nutrition Program Towards Reducing HbA1c
RECRUITING · NA
-
Targeting Metabolic Syndrome From the Emergency Department Through Mixed-Methods: Pilot Trial
RECRUITING · NA
-
Maturation of Arteriovenous Fistula With Automated Sonography Assessments Trial
RECRUITING · NA
-
Bringing Advocacy Via Digital Guide to the Emergency Department (Project BADGE)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03292601 · 87 participants · NA
Brace Monitoring for Adolescent Idiopathic Scoliosis (AIS)
- NCT04291105 · 87 participants · Phase 2
Phase 2 Trial of Voyager V1 in Combination With Cemiplimab in Cancer Patients
- NCT04565795 · 87 participants · NA
Safety and Device Performance of the Uriprene® Degradable Temporary Ureteral Stent Following Uncomplicated Ureteroscopy
- NCT05607004 · 87 participants · Phase 2
(Z)-Endoxifen for the Treatment of Premenopausal Women With ER+/HER2- Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI